Keshani Hiniduma

Dr. Keshani Hiniduma

Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
DWD. Randil K. Weerasuriya
D. Randil K. Weerasuriya
SBSnehasis Bhakta
Snehasis Bhakta
Keshani HinidumaKeshani Hiniduma
Keshani Hiniduma
CDChandra K. Dixit
Chandra K. Dixit
MSMin Shen
Min Shen
James RuslingJames Rusling
James Rusling

30 November 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
Keshani HinidumaKeshani Hiniduma
Keshani Hiniduma
KBKetki S. Sharad Bhalerao
Ketki S. Sharad Bhalerao
PSPeyahandi I. Thilini De Silva
Peyahandi I. Thilini De Silva
TCTianqi Chen
Tianqi Chen
James RuslingJames Rusling
James Rusling
Microfluidic technology has revolutionized device fabrication by merging principles of fluid dynamics with technologies from chemistry, physics, biology, material science, and microelectronics. Microfluidic systems manipulate small volumes of fluids to perform automated tasks with applications ranging from chemical syntheses to biomedical diagnostics. The advent of low-cost 3D printers has revolutionized the development of microfluidic systems. For measuring molecules, 3D printing offers cost-effective, time, and ease-of-designing benefits. In this paper, we present a comprehensive tutorial for design, optimization, and validation for creating a 3D-printed microfluidic immunoarray for ultrasensitive detection of multiple protein biomarkers. The target is the development of a point of care array to determine five protein biomarkers for aggressive cancers. The design phase involves defining dimensions of microchannels, reagent chambers, detection wells, and optimizing parameters and detection methods. In this study, the physical design of the array underwent multiple iterations to optimize key features, such as developing open detection wells for uniform signal distribution and a flap for covering wells during the assay. Then, full signal optimization for sensitivity and limit of detection (LOD) was performed, and calibration plots were generated to assess linear dynamic ranges and LODs. Varying characteristics among biomarkers highlighted the need for tailored assay conditions. Spike-recovery studies confirmed the assay’s accuracy. Overall, this paper showcases the methodology, rigor, and innovation involved in designing a 3D-printed microfluidic immunoarray. Optimized parameters, calibration equations, and sensitivity and accuracy data contribute valuable metrics for future applications in biomarker analyses.

18 August 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Keshani HinidumaKeshani Hiniduma
Keshani Hiniduma
PSP.I. Thilini De Silva
P.I. Thilini De Silva
RCRachelle Canete
Rachelle Canete
PVPalash Vora
Palash Vora
HGHansana Gunathillaka
Hansana Gunathillaka
James RuslingJames Rusling
James Rusling

29 May 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
PSP. I. Thilini De Silva
P. I. Thilini De Silva
Keshani HinidumaKeshani Hiniduma
Keshani Hiniduma
RCRachelle Canete
Rachelle Canete
KBKetki S. Sharad Bhalerao
Ketki S. Sharad Bhalerao
SSsherif Shawky
sherif Shawky
James RuslingJames Rusling
James Rusling
CRISPR-Cas proteins from bacteria are powerful tools for gene editing and molecular diagnostics. Expanding capacity of CRISPR to low cost, multiplexed assays of biomarkers is a key to future disease diagnostics, since multiple biomarker detection is essential for reliable diagnostics. Herein we describe a multiplexed assay in a 3D-printed 96-well plate with CRISPR-Cas13a immobilized in each well to target three circulating blood biomarker microRNAs (miRNAs 34c-5p, 200c-3p, and 30e-5p) for Alzheimer’s disease (ALZ). Immobilized Cas13a is equipped with different crRNAs complementary to each miRNA target. MiRNA binding to crRNA complements activates the collateral RNase activity of Cas13a, cleaving a quenched fluorescent reporter (RNaseAlert) with fluorophore and quencher connected by an RNA oligonucleotide to enable fluorescence measurements. We achieved ultralow limits of detection (LOD) of 0.74 fg/mL for miRNA 34c-5p, 0.70 fg/mL for miRNA 30e-5p, and 7.4 fg/mL for miRNA 200c-3p, with dynamic ranges from LODs up to about 1800 pg/mL. The accuracy of the assay was validated by spike-recovery studies and good correlation of levels of patient plasma samples vs. a referee method. This new approach provides selective, sensitive multiplex miRNA biosensing, and simultaneously accommodates analysis of standards and controls.

23 January 2023 in ACS Sensors
Verified
Journal Article
Closed access
DWD. Randil K. Weerasuriya
D. Randil K. Weerasuriya
Keshani HinidumaKeshani Hiniduma
Keshani Hiniduma
SBSnehasis Bhakta
Snehasis Bhakta
LNLisa M. Nigro
Lisa M. Nigro
LPLuisa F. Posada
Luisa F. Posada
James RuslingJames Rusling
James Rusling